Select Page
FDA Grants IDE to ZOLL Medical for ISO Shock Study

FDA Grants IDE to ZOLL Medical for ISO Shock Study

The U.S. Food and Drug Administration (FDA) has granted ZOLL Medical investigational device exemption (IDE) for a randomized study to evaluate TherOx® SuperSaturated Oxygen (SSO2) Therapy in patients with cardiogenic shock and ST Elevation Myocardial Infarction...